These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 16573255

  • 1. Combination topical therapy for the treatment of psoriasis.
    Del Rosso Do JQ.
    J Drugs Dermatol; 2006 Mar; 5(3):232-4. PubMed ID: 16573255
    [Abstract] [Full Text] [Related]

  • 2. A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes.
    Koo J, Blum RR, Lebwohl M.
    J Am Acad Dermatol; 2006 Oct; 55(4):637-41. PubMed ID: 17010744
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Topical application of calcipotriene and corticosteroids: combination regimens.
    Lebwohl M.
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S55-8. PubMed ID: 9344186
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J, Bjerke JR, Gjertsen BT, Helland S, Livden JK, Morken T, Mørk NJ.
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [Abstract] [Full Text] [Related]

  • 8. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
    Menter A, Abramovits W, Colón LE, Johnson LA, Gottschalk RW.
    J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
    [Abstract] [Full Text] [Related]

  • 9. A multi-center, open-label study to evaluate the safety and efficacy of a sequential treatment regimen of clobetasol propionate 0.05% spray followed by Calcitriol 3 mg/g ointment in the management of plaque psoriasis.
    Brodell RT, Bruce S, Hudson CP, Weiss JS, Colón LE, Johnson LA, Gottschalk RW.
    J Drugs Dermatol; 2011 Feb; 10(2):158-64. PubMed ID: 21283920
    [Abstract] [Full Text] [Related]

  • 10. Calcitriol 3 microg/g ointment: an effective and safe addition to the armamentarium in topical psoriasis therapy.
    Abramovits W.
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s17-22. PubMed ID: 19702032
    [Abstract] [Full Text] [Related]

  • 11. Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement.
    Lebwohl M, Yoles A, Lombardi K, Lou W.
    J Am Acad Dermatol; 1998 Sep; 39(3):447-50. PubMed ID: 9738781
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. An open-label, multicenter study of the efficacy and safety of a weekday/weekend treatment regimen with calcitriol ointment 3 microg/g and clobetasol propionate spray 0.05% in the management of plaque psoriasis.
    Hudson CP, Kempers S, Menter A, Papp K, Smith S, Sofen H, Colón LE, Johnson LA, Gottschalk R.
    Cutis; 2011 Oct; 88(4):201-7. PubMed ID: 22106730
    [Abstract] [Full Text] [Related]

  • 14. Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study.
    Bowman PH, Maloney JE, Koo JY.
    J Am Acad Dermatol; 2002 Jun; 46(6):907-13. PubMed ID: 12063489
    [Abstract] [Full Text] [Related]

  • 15. Clobetasol propionate for psoriasis: are ointments really more potent?
    Warino L, Balkrishnan R, Feldman SR.
    J Drugs Dermatol; 2006 Jun; 5(6):527-32. PubMed ID: 16774104
    [Abstract] [Full Text] [Related]

  • 16. The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasis.
    Lebwohl M, Colón LE.
    Cutis; 2007 Nov; 80(5 Suppl):29-40. PubMed ID: 18154221
    [Abstract] [Full Text] [Related]

  • 17. Management of psoriasis with calcipotriol used as monotherapy.
    Ramsay CA.
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S53-4. PubMed ID: 9344185
    [Abstract] [Full Text] [Related]

  • 18. Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis.
    Stein L.
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S39-49. PubMed ID: 15968263
    [Abstract] [Full Text] [Related]

  • 19. Calcipotriene/betamethasone in the treatment of psoriasis: a review article.
    Saraceno R, Gramiccia T, Frascione P, Chimenti S.
    Expert Opin Pharmacother; 2009 Oct; 10(14):2357-65. PubMed ID: 19663634
    [Abstract] [Full Text] [Related]

  • 20. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
    Housman TS, Keil KA, Mellen BG, McCarty MA, Fleischer AB, Feldman SR.
    J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.